ARCH Venture Fund VII L.P. 13D/13G Filings for Unity Biotechnology, Inc. (UBX)

ARCH Venture Fund VII L.P. 13D and 13G filings for Unity Biotechnology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-11
4:55 pm
Purchase		 2021-12-31 13G Unity Biotechnology, Inc.
UBX		 ARCH Venture Fund VII L.P. 1,013,886
17.500%		 3,856increase
(+0.38%)		 Filing
2021-02-02
5:03 pm
Purchase		 2020-12-31 13G Unity Biotechnology, Inc.
UBX		 ARCH Venture Fund VII L.P. 1,010,030
19.100%		 3,856increase
(+0.38%)		 Filing